リコンビナント
RabMAb

Anti-Tau (phospho S396) 抗体 [EPR2731] (ab109390)

ab109390 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab109390 は 8 報の論文で使用されています。

  • Sadick JS  et al. Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations. Sci Rep 6:33999 (2016). WB, ICC/IF ; Human . PubMed: 27666089
  • Guo C  et al. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model. Sci Rep 6:29396 (2016). PubMed: 27406855
  • Tan Y  et al. 7,8-Dihydroxyflavone Ameliorates Cognitive Impairment by Inhibiting Expression of Tau Pathology in ApoE-Knockout Mice. Front Aging Neurosci 8:287 (2016). WB ; Mouse . PubMed: 27965573
  • Choi WH  et al. Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun 7:10963 (2016). PubMed: 26957043
  • Kim D  et al. Identification of disulfide cross-linked tau dimer responsible for tau propagation. Sci Rep 5:15231 (2015). ICC/IF . PubMed: 26470054
  • Han DH  et al. Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun 5:5633 (2014). PubMed: 25476420
  • Manczak M & Reddy PH Abnormal interaction of oligomeric amyloid-ß with phosphorylated tau: implications to synaptic dysfunction and neuronal damage. J Alzheimers Dis 36:285-95 (2013). IP, WB ; Human . PubMed: 23594602
  • Murakami K  et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid ß protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286:44557-68 (2011). WB . PubMed: 22072713

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録